- 105-5 Quarry Ridge Rd. Barrie, On, L4M 7G1
Chronic eczema of
the hands and feet?
A clinical trial could
help explore new options
Up to 10% of people deal with chronic hand eczema.
Finding relief can be elusive.
This study is to evaluate an investigational novel biologic for its effectiveness in treating chronic hand and foot eczema.
Do I qualify
Participants must meet the criteria to be enrolled in the study.
You may qualify if you:
- are 12 years of age or older at the time of screening.
- have had a diagnosis of chronic hand or foot eczema for at least one year.
- have eczema on at least two hands, two feet, or one foot and one hand.
- do not have any other conditions on your hands or feet that could affect the study results.
There is no cost to participate – and there may be compensation
for study related expenses.
What happens during the study?
The trial lasts about 28 weeks (not including screening), and involves about 7 visits to the clinic in Barrie.
Participants have a 50% chance to receive the active study drug, or the placebo.
Before joining, you’ll review details of participating, and be able to ask any questions.
There are three stages to the trial:
Screening
Study coordinators meet with all applicants to determine eligibility and health exams.
This will give the researchers a baseline and helps ensure the safety of participants
Treatment
16 Weeks
Participants will receive either the active study drug or the placebo, and attend clinic visits roughly once every two weeks for medical examination.
Doctors will mark the progress of eczema symptoms for the study.
Follow-Up
12 Weeks
One final visit to the clinic for closing medical examination.
Why participate?
Potential to find relief.
To help others with chronic hand and foot eczema have better options in the future.
Continuous monitoring from a top dermatologist specialized and committed to patients with eczema.
Do I qualify?
Participants must meet the criteria to be enrolled in the study.
There are additional criteria that apply.
You may qualify if you:
- are 12 years of age or older at the time of screening.
- have had a diagnosis of chronic hand or foot eczema for at least one
year. - have eczema on at least two hands, two feet, or one foot and one hand.
- do not have any other conditions on your hands or feet that could affect the study results.
There is no cost to participate – and there may be compensation for study related expenses.
*There are further criteria for participation. Only study coordinators can determine your eligibility.
What happens during the study?
The trial lasts about 28 weeks not including screening, and involves about 7 visits to the clinic in Barrie.
Participants have a 50% chance to receive the active study drug, or the placebo.
There are three periods to the trial: screening, treatment, and follow-up.
Screening is first, and is when study coordinators will meet with all interested applicants to determine true eligibility and to preform health exams. This will give the researchers a baseline and help ensure
the safety of participants.
Once the screening is done, the treatment period begins.
Participants will receive either the active study drug or the placebo for 16 weeks, and attend clinic visits roughly once every two weeks for medical examination. Doctors will mark the progress of eczema symptoms for the study.
After the 16 week treatment phase, there is a 12 week follow-up. This involves one final visit to the clinic for medical examination, and helps research how long any positive effects might last.
Before joining, you’ll review everything about participating, and be able to ask any questions.
We wont enrol you without your signed consent, and you can quit the trial at any time, for any reason.
Why participate?
Potential to find relief.
To help others with chronic hand and foot eczema have better options in the future.
Continuous monitoring from a top dermatologist specialized and committed
to patients with eczema.
Do I qualify?
Participants must meet the criteria to be enrolled in the study.
There are additional criteria that apply.
You may qualify if you:
- are 12 years of age or older at the time of screening.
- have had a diagnosis of chronic hand or foot eczema for at least one year.
- have eczema on at least two hands, two feet, or one foot and one hand.
- do not have any other conditions on your hands or feet that could affect the study results.
What happens during the study?
Summary
The trial lasts about 28 weeks not including screening, and involves about 7 visits to the clinic in Barrie.
Participants have a 50% chance to receive the active study drug, or the placebo.
There are three periods to the trial: screening, treatment, and follow-up.
Before joining, you’ll review everything involved in participating, and be able to ask any questions.
Screening Phase
Screening is first. Study coordinators will meet with applicants to determine eligibility and for health exams. This gives researchers a baseline and help ensure the safety of participants.
Treatment Phase
Once the screening is done, the treatment period begins.
For 16 weeks participants will receive either the active study drug or the placebo. They will attend clinic visits roughly once every two weeks for medical examination. Doctors will mark the progress of eczema symptoms for the study.
Follow-up Phase
After the 16 week treatment phase, there is a 12 week follow-up.
This involves one final visit to the clinic for medical examination. This helps
research how long any positive effects might last.
Why participate?
Potential to find relief.
To help others with chronic hand and foot eczema have better options in the future.
Continuous monitoring from a top dermatologist specialized and committed to patients with eczema.
Frequently Asked Questions (FAQ)
Need assistance?
Call us
Monday – Friday
9:00 a.m. – 4:00 p.m.
# (289)-763-7666
OR Email trialsupportteam@simcoderm.com
Monday – Friday
9:00 a.m. – 4:00 p.m.
# (289)-763-7666
OR Email trialsupportteam@simcoderm.com
Informed consent means you’ll receive all the important information about the study; what’s involved, any risks, and your rights, before you decide to join. You can ask questions and choose whether or not to participate.
A clinical trial is a medical study that helps researchers learn whether a treatment is safe and effective. By joining, you’re helping to advance care for eczema.
You may receive access to a study drug at no cost for your eczema, receive care from a dedicated medical team, and contribute to research that could help others.
Yes. Your safety is our top priority. The study follows strict safety rules, is reviewed by independent ethics boards, and you’ll be closely monitored by medical professionals throughout your participation.
All treatments have potential risks or side effects.
We’ll explain these clearly before you join, and you’ll be supported every step of the way to make sure you feel comfortable and informed.
No. You do not need insurance to participate in the trial.
Do I qualify?
Participants must meet the criteria to be enrolled in the study.
There are additional criteria that apply.
You may qualify if you:
- are 12 years of age or older at the time of screening.
- have had a diagnosis of chronic hand or foot eczema for at least one
year. - have eczema on at least two hands, two feet, or one foot and one hand.
- do not have any other conditions on your hands or feet that could affect the study results.
There is no cost to participate – and there may be compensation for study related expenses.
*There are further criteria for participation. Only study coordinators can determine your eligibility.
What happens during the study?
Study Details
The trial lasts about 28 weeks not including screening, and involves about 7
visits to the clinic in Barrie.
Participants have a 50% chance to receive the active study drug, or the placebo.
There are three periods to the trial: screening, treatment, and follow-up.
Screening is first, and is when study coordinators will meet with all interested applicants to determine true eligibility and to preform health exams. This will give the researchers a baseline and help ensure
the safety of participants.
Once the screening is done, the treatment period begins.
Participants will receive either the active study drug or the placebo for 16 weeks, and attend clinic visits roughly once every two weeks for medical examination. Doctors will mark the progress of eczema symptoms for the study.
After the 16 week treatment phase, there is a 12 week follow-up. This involves one final visit to the clinic for medical examination, and helps
research how long any positive effects might last.
Before joining, you’ll review everything about participating, and be able
to ask any questions.
We wont enrol you without your signed consent, and you can quit the trial
at any time, for any reason.
Why participate?
Potential to find relief.
To help others with chronic hand and foot eczema have better options in the future.
Continuous monitoring from a top dermatologist specialized and committed
to patients with eczema.
Application Form
Submit the form below to apply.
This information is 100% confidential and only used to determine your eligibility.
We will call you within 1 business day to confirm your interest in the trial.
Frequently Asked Questions (F.A.Q.)
Informed consent means you’ll receive all the important information about the study; what’s involved, any risks, and your rights, before you decide to join. You can ask questions and choose whether or not to participate.
A clinical trial is a medical study that helps researchers learn whether a treatment is safe and effective. By joining, you’re helping to advance care for eczema.
You may receive access to a study drug at no cost for your eczema, receive care from a dedicated medical team, and contribute to research that could help others.
Yes. Your safety is our top priority. The study follows strict safety rules, is reviewed by independent ethics boards, and you’ll be closely monitored by medical professionals throughout your participation.
All treatments have potential risks or side effects.
We’ll explain these clearly before you join, and you’ll be supported every step of the way to make sure you feel comfortable and informed.
No. You do not need insurance to participate in the trial.
Call us Mon–Fri.
9:00 a.m. – 4:00 p.m.
#289-763-7666
Or email trialsupportteam@simcoderm.com
© 2025 SimcoDerm